A new high has been reached for the cannabis industry as the New York Stock Exchange has given its approval to list a marijuana company on the exchange for the first time.
Innovative Industrial Properties, who targets medical-use cannabis facilities for acquisition with tenants that are licensed growers, was given approval by the NYSE for initial public offering, according to Forbes, and plans to list under the symbol IIPR.
The company had filed its IPO in the middle of October, noting the intention to raise $175 million through 8.8 million shares at $20 each, giving the valuation of the company at $202 million.
Forbes noted the REIT confirmed the listing was approved on November 17, but the NYSE has yet to discuss it.
Keeping in mind, however, recreational marijuana is still federally illegal, although four states voted in favor for its legalization the day of the US election (November 8).  Because of this, Forbes said the NYSE could be pushing its own boundaries by listing a company that is not in compliance with the law.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

In an interview with Forbes, Jeremy Unruh, general counsel of PharmaCann said Innovative Industrial Properties’ publicly-traded REIT will be the first opportunity industrial investors have to generate exposure in an industry lacking transparency.
“The IIP listing on the NYSE is every bit as important to the cannabis movement as the Rohrabacher-Farr Amendment barring the DOJ from spending federal funding to enforce the Controlled Substance Act against responsible medical cannabis licensees, or the commitment of Scott’s Miracle Gro to the cannabis industry,” Unruh said. 
Gregory M. Sale from Seyfarth Shaw LLP wrote that the NYSE listing is “big news for the cannabis industry” because a listing on a major exchange “lends a measure of mainstream credibility to the industry, as well as greater access to investor dollars.”
With that in mind, Bloomberg reported recreational cannabis in the United States is estimated to be worth nearly $20 billion, and will no doubt continue blooming.
Clearly, exciting times are ahead for the cannabis industry. Although there’s no official word on whether or not the NYSE will list more marijuana-related companies on its exchange, Isaac Dietrich of Mass Roots told Forbes that exchanges are taking the industry’s growth “very seriously.”
Don’t forget to follow us @INN_Resource for real-time news updates.
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less